HONG KONG – Chugai Pharmaceutical Co. Ltd., a Japanese subsidiary of Roche Holding AG, won approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Foundationone CDx, Foundation Medicine Inc.'s genomic profiling test for solid tumors and companion diagnostics for molecularly targeted drugs.